Refine
Has Fulltext
- yes (61)
Is part of the Bibliography
- yes (61)
Year of publication
Document Type
- Journal article (56)
- Report (2)
- Review (2)
- Book article / Book chapter (1)
Language
- English (61)
Keywords
- amyotrophic lateral sclerosis (4)
- Neurotrophic factors (3)
- ciliary neurotrophic factor (3)
- spinal muscular atrophy (3)
- BDNF (2)
- CNTF (2)
- RNA (2)
- Schwann cells (2)
- TrkB (2)
- autophagy (2)
- motoneurons (2)
- neuromuscular junction (2)
- neurons (2)
- spinal cord (2)
- synaptic plasticity (2)
- 3D cell culture (1)
- Aging (1)
- Alzheimer's disease (1)
- Alzheimers disease (1)
- Alzheimer’s disease (1)
- Amyotrophic-lateral-sclerosis (1)
- Associative learning (1)
- Astrocytes ; Schwann cells ; Interferon-gamma ; Fibroblast growth factor ; Cyclic AMP (1)
- Axon degeneration (1)
- Axon growth (1)
- Axonal degeneration (1)
- Axonal transport (1)
- BDNF stimulation (1)
- BSTA (1)
- Brain (1)
- C. elegans (1)
- C9orf72 (1)
- Cells (1)
- DAPI staining (1)
- DNA repeat expansion (1)
- DRD1 (1)
- Diabetic polyneuropathy (1)
- Drosophilia (1)
- Exercise (1)
- FGF-5 (1)
- Facial Nerve Transection (1)
- Fear conditioning (1)
- Fibroblast Growth Factor (1)
- GPCR (1)
- Glutamatergic synapses (1)
- Hippocampus (1)
- IGF-I (1)
- Immunopanning (1)
- Insulinlike Growth Factor (1)
- Intermediate filaments (1)
- Lacking neurofilaments (1)
- MAP1B (1)
- Microtubules (1)
- Missense mutation (1)
- Molecular neuroscience (1)
- Motoneuron disease (1)
- Motor behaviour (1)
- Motor nerve biopsy (1)
- Motor neuron disease; Ciliary neurotrophic factor; Brain-derived neurotrophic factor; Animal models; Neurotrophic factors (1)
- Mouse model (1)
- Mus spretus (1)
- NGF gene family (1)
- NMJ–neuromuscular junction (1)
- Nervenzelle (1)
- Neurobiologie (1)
- Neurofilament (1)
- Neuropathy (1)
- Neurotrophin (1)
- Object recognition (1)
- PKB/Akt phosphorylation (1)
- PLEKHG5 (1)
- Phosphorylation (1)
- Plasma-membrane (1)
- Pleckstrin homology containing family member 5 (Plekhg5) (1)
- Progressive motor neuronopathy (1)
- Protein kinase B (1)
- RNA splicing (1)
- RNA transport (1)
- RNA-binding proteins (1)
- Rictor-mTOR complex (1)
- SAP47 gene (1)
- SMN (1)
- SMN granules (1)
- Spinal Muscular-arthropy (1)
- Stat3 (1)
- Stathmin (1)
- Syap1 knockout (1)
- Syap1 localization (1)
- Tdp-43 (1)
- Transcription (1)
- Transgenic mice (1)
- Vascular plasticity (1)
- Viability (1)
- YB-1 (1)
- actin messenger RNA (1)
- adenocarcinoma of the lung (1)
- apoptosis (1)
- axonal degeneration (1)
- axonal transcriptome (1)
- axons (1)
- basal ganglia (1)
- cerebral blood flow (1)
- chick (1)
- ciliary neuron (1)
- ciliary neurotrophic factor (CNTF) (1)
- ciliary-neurotrophic factor (1)
- comet assay (1)
- cortico-striatal synapse (1)
- cross-sectional studies (1)
- cytosol (1)
- dSPN (1)
- degeneration (1)
- demyelination (1)
- determining gene-product (1)
- direct pathway (1)
- dynamics of ribosomal assembly (1)
- early-onset predictors (1)
- electron tomography (1)
- enrichment (1)
- exercise (1)
- factor prevents (1)
- frontotemporal dementia (1)
- fused in sarcoma (1)
- gene targeting (1)
- genome wide (1)
- genome-wide association studies (1)
- hippocampus (1)
- homologous recombination (1)
- iPSC (induced pluripotent stem cells) (1)
- immune response (1)
- immunoprecipitation (1)
- injury (1)
- insulin (1)
- insulin-likegrowth factor I (1)
- interacts (1)
- interleukin 6 (1)
- interspeific backcross (1)
- lIF (1)
- linkage (1)
- lung and intrathoracic tumors (1)
- medicine (1)
- memory (1)
- metastasis (1)
- mild cognitive impairment (1)
- molecular neuroscience (1)
- motoneuron (1)
- motoneuron (MN) (1)
- motoneuron disease (1)
- motor axons (1)
- motor learning (1)
- motor neuron degeneration (1)
- mulitple-sclerosis patients (1)
- myelin (1)
- nerve lesion (1)
- neurofilaments (1)
- neuron migration (1)
- neurotrophic factor (1)
- neurotrophic molecules (1)
- neurotrophins (1)
- nicotinamide (1)
- non-small cell lung cancer (1)
- nonneuronaI cells (1)
- nuclear ribonucleoprotein-R (1)
- presynaptic ER dynamics (1)
- programmed cell death (1)
- protein interactions (1)
- rat (1)
- receptor (1)
- recombinant proteins (1)
- regulation (1)
- restriction fragment length polymorphism (1)
- secondary lung tumors (1)
- skeletal muscle (1)
- subcellular trafficking (1)
- survival (1)
- synaptic vesicles (1)
- thoracic diaphragm (1)
- transactivation (1)
- transcription-3 (STAT3) (1)
- uper-resolution array tomography (1)
- vector cloning (1)
- β-actin mRNA (1)
Institute
- Institut für Klinische Neurobiologie (58)
- Theodor-Boveri-Institut für Biowissenschaften (5)
- Neurologische Klinik und Poliklinik (4)
- Institut für Anatomie und Zellbiologie (3)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (2)
- Frauenklinik und Poliklinik (1)
- Institut für Psychologie (1)
- Lehrstuhl für Biochemie (1)
- Medizinische Klinik und Poliklinik II (1)
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that affects 1 in ~350 individuals. Genetic association studies have established ALS as a multifactorial disease with heritability estimated at ~61%, and recent studies show a prominent role for rare variation in its genetic architecture. To identify rare variants associated with disease onset we performed exome array genotyping in 4,244 cases and 3,106 controls from European cohorts. In this largest exome-wide study of rare variants in ALS to date, we performed single-variant association testing, gene-based burden, and exome-wide individual set-unique burden (ISUB) testing to identify single or aggregated rare variation that modifies disease risk. In single-variant testing no variants reached exome-wide significance, likely due to limited statistical power. Gene-based burden testing of rare non-synonymous and loss-of-function variants showed NEK1 as the top associated gene. ISUB analysis did not show an increased exome-wide burden of deleterious variants in patients, possibly suggesting a more region-specific role for rare variation. Complete summary statistics are released publicly. This study did not implicate new risk loci, emphasizing the immediate need for future large-scale collaborations in ALS that will expand available sample sizes, increase genome coverage, and improve our ability to detect rare variants associated to ALS.